Earnings Call · Q4 FY2022·2023-03-09

Q4 22EPS +29.03%·Rev n/aQ3 22EPS +19.35%·Rev n/aQ2 22EPS 0.00%·Rev n/aQ1 22EPS 0.00%·Rev n/a⚠ consensus missing

Aldeyra Therapeutics, Inc. ALDX

Bruce Greenberg — Chief Financial Officer

Todd Brady — President and Chief Executive Officer

+7.2%1d on move date+9.0% vs SPY3d−4.7%5d+6.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALDX calls or request research access.

More ALDX calls Browse calls Request research access